Dividends4Life: High-Yield Pharmaceutical Dividend Stocks

High-Yield Pharmaceutical Dividend Stocks

Posted by D4L | Sunday, December 01, 2013 | | 0 comments »

If you're a conservative investor looking for a high yield plus the potential for price appreciation, you may be doing yourself a disservice by sticking to the bond universe. For Foolish investors, stable stocks with growing dividends are always worth a look. When looking for solid dividend stocks, I try to look for a combination of excellent dividend-raising history, high current yield, and superior potential for earnings growth. Earnings are important, and you should also examine the projected five-year earnings growth rate, as well as the current P/E ratio.

Here are three pharmaceutical companies to consider for investors looking to get exposure to this sector: AbbVie (NYSE: ABBV) has a 3.3% yield, and the stock is up 44% since it began trading in January; it's currently just off its all-time high of $50. Teva Pharmaceuticals (NYSE: TEVA), the Israel-based company known mostly for its line of generic drugs, is currently trading at around $38 and yields 3.4%; the company has been raising dividends consistently for 14 years and has an impressive five-year dividend growth rate of 21.8%. AstraZeneca (NYSE: AZN) is currently trading at $53 and yields 3.4%; the company has a five-year dividend growth rate of 8.2%.

Source: Motley Fool

Related Articles:
- 3 Styles Of Successful Dividend Investing
- 8 Higher-Yielding Financial Services Stocks With Rising Dividends
- 5 Quality Dividend Stocks To Take The Emotion Out Of Investing
- 7 Select High-Yield S&P 500 Dividend Stocks
- A Winning Investment Strategy

Click here to have future posts delivered to you for free!



Post a Comment

Note: Only a member of this blog may post a comment.


Popular Posts Last 30 Days